Patricia A. Warfel, B.S.

Director
Spero Therapeutics

Disclosure: No financial relationships or conflicts of interest

Presentation(s):

• LB-3 - Oral Tebipenem Pivoxil Hydrobromide is Non-inferior to IV Ertapenem in Complicated Urinary Tract Infection (cUTI) and Acute Pyelonephritis (AP) – Results from the Pivotal ADAPT-PO Study

  Saturday, October 24, 2020
  10:10am – 10:20am EDT